Form 8-K Toast, Inc. For: Sep 28
0001650164FALSE00016501642026-09-282026-09-28UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549___________________________________FORM 8-K___________________________________CURRENT REPORT PURSUANTTO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Date of Report (Date of earliest event reported): September 28, 2026___________________________________Toast, Inc.(Exact name of registrant as specified in its charter) ... (continue reading...)
Form 8-K Brightline Interactive, For: Oct 01
false
0001854445
0001854445
2026-10-01
2026-10-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or... (continue reading...)
Form 8-K Valion Bio, Inc. For: Sep 30
false
0001787740
0001787740
2026-09-30
2026-09-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the... (continue reading...)
Form 8-K Vylor Inc. For: Oct 01
false 0002128626 0002128626 2026-10-01 2026-10-01
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 1, 2026
Vylor Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware 001-43376 41-2930124 (State or Other Jurisdictionof Incorporation) ... (continue reading...)
Form 144 ORAMED PHARMACEUTICALS Filed by: Gabay Avraham
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K EIDP, Inc. For: Oct 01 Filed by: Corteva, Inc.
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Hexter Joshua
-
Form 8-K Monte Rosa Therapeutics, For: Oct 01
-
Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
-
Form F-X TSUKISHIMA HOLDINGS CO., Filed by: Mitsubishi Kakoki Kaisha, Ltd.
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K Installed Building Produ For: Oct 01
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K MCCORMICK & CO INC For: Oct 01
-
Form 1-SA RSE Collection, LLC For: Jun 30
-
Form 8-K CHESAPEAKE UTILITIES For: Sep 30
-
Form 8-K CIVISTA BANCSHARES, INC. For: Oct 01
-
Form 8-K FrontView REIT, Inc. For: Oct 01
-
Form 8-K KYNTRA BIO, INC. For: Sep 30
-
Form 3/A CRH PUBLIC LTD CO For: Jul 01 Filed by: Will W Anthony
-
Form 40-17G Bitwise Funds Trust
-
Form 424B3 SCHMID Group N.V.
-
Form 424B3 SCHMID Group N.V.
-
Form 10-12G/A Third Point Private Capi
-
Form CERT T. Rowe Price Exchange-T
-
Form 6-K Arcos Dorados Holdings For: Oct 01
-
Form 8-K ACUITY INC. (DE) For: Oct 01
-
Form 4 Costamare Inc. For: Sep 30 Filed by: Konstantakopoulos Konstantinos
-
Form 8-K Slam Corp. For: Sep 28
-
Form 8-K Keurig Dr Pepper Inc. For: Oct 01
-
Form 425 Newbury Street II Acquis Filed by: Newbury Street II Acquisition Corp
-
Form 8-K KIMBERLY CLARK CORP For: Sep 29
-
Form 8-K Fervo Energy Co For: Oct 01
-
Form 8-K Ovintiv Inc. For: Oct 01
-
Form 6-K PEARSON PLC For: Oct 01
-
Form 8-K D-Wave Quantum Inc. For: Oct 01
-
Form 8-K Foghorn Therapeutics For: Sep 25
-
Form 8-K Sadot Group Inc. For: Sep 30
-
Form 8-K INNOVATIVE INDUSTRIAL For: Sep 28
-
Form 8-K VerifyMe, Inc. For: Oct 01
-
Form 8-K NATIONAL FUEL GAS CO For: Oct 01
-
Form D CrownForge Energy Fund
-
Form 8-K CARDINAL HEALTH INC For: Oct 01
-
Form 8-K CENTERPOINT ENERGY RESOU For: Oct 01 Filed by: CENTERPOINT ENERGY INC
-
Form 6-K GFL Environmental Inc. For: Oct 01
-
Form 8-K AMERICAN VANGUARD CORP For: Oct 01
-
Form S-4 REEcycle Holdings, Inc. Filed by: Hall Chadwick Acquisition Corp
-
Form 6-K PEARSON PLC For: Oct 01
-
Form 6-K Costamare Inc. For: Sep 30
-
Form 8-A12B/A T. Rowe Price Exchange-T
-
Form 6-K RYANAIR HOLDINGS PLC For: Oct 01
-
Form 6-K AgomAb Therapeutics NV For: Oct 01
-
Form 8-K Accenture plc For: Oct 01
-
Form 8-K JOINT Corp For: Oct 01
-
Form D Solace Capital Ltd.
